Bill Status of HB 3454   104th General Assembly

Short Description:  EPINEPHRINE DELIVERY DEVICE

House Sponsors
Rep. Joyce Mason, Jawaharial Williams, Harry Benton, Dagmara Avelar and Camille Y. Lilly

Last Action  View All Actions

DateChamber Action
  4/11/2025HouseRule 19(a) / Re-referred to Rules Committee

Statutes Amended In Order of Appearance
20 ILCS 2610/40
50 ILCS 705/10.19
105 ILCS 5/22-30
215 ILCS 5/356z.33
225 ILCS 60/65
410 ILCS 27/1
410 ILCS 27/5
410 ILCS 27/10
410 ILCS 27/15
410 ILCS 27/20
410 ILCS 607/10
410 ILCS 620/3.21from Ch. 56 1/2, par. 503.21
410 ILCS 642/20

Synopsis As Introduced
Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.

Actions 
DateChamber Action
  2/7/2025HouseFiled with the Clerk by Rep. Joyce Mason
  2/18/2025HouseFirst Reading
  2/18/2025HouseReferred to Rules Committee
  3/11/2025HouseAssigned to Prescription Drug Affordability & Accessibility Committee
  3/19/2025HouseDo Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000
  3/20/2025HousePlaced on Calendar 2nd Reading - Short Debate
  3/26/2025HouseAdded Co-Sponsor Rep. Jawaharial Williams
  3/26/2025HouseAdded Co-Sponsor Rep. Harry Benton
  3/26/2025HouseAdded Co-Sponsor Rep. Dagmara Avelar
  3/26/2025HouseSecond Reading - Short Debate
  3/26/2025HouseHeld on Calendar Order of Second Reading - Short Debate
  4/8/2025HouseAdded Co-Sponsor Rep. Camille Y. Lilly
  4/11/2025HouseRule 19(a) / Re-referred to Rules Committee

Back To Top